We are excited to announce that this year's Seminar will be held on November 4, 2023 at the OHSU-Robertson Life Sciences Building in Portland, Oregon.  

Seminar Event Details
November 4, 2023

OHSU Robertson Life Sciences Building
2730 S Moody Ave
Portland, OR 97201

CE Credit
This activity has been planned and implemented in accordance with the policies of the Accreditation Council on Pharmacy Education (ACPE) through the joint providership of the Oregon State University College of Pharmacy and Oregon Society for Health-System Pharmacists (OSHP). Oregon State University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been approved for up to 5 hour(s) of ACPE accredited continuing pharmacy education. 

Disclosures: None of the planners or presenters for this program have any financial relationships with ineligible companies to disclose. 

An ACPE Statement of Credit shall be issued to participants only after successful completion of the activity. Internet access is required for successful completion. Successful completion is defined as: 1) Attending, in its entirety, the CPE activity and receiving the unique activity Credit Code; 2) Participating in the pre-test administered by the presenter(s); 3) Completing the online activity evaluation and self-evaluation quiz located at:http://pharmacy.oregonstate.edu/ce within 60 days of program attendance. The Statement of Credit will be uploaded to the participant’s CPE Monitor automatically within 48 hours of successful activity completion. It is the participant’s responsibility to complete the online components (Step 3) within 60 days of program attendance. Credit will not be provided after 60 days.

Click here for ACPE information.

Registration 
Your registration includes: All education sessions and materials, access to exhibits, continental breakfast, lunch and refreshment breaks. 

• OSHP/OSPA Members: Pharmacist – $200.00 | Supporting Associate (Industry) – $200.00
• Non Members: Pharmacist – $320.00 | Supporting Associate (Industry) – $320.00
• Pharmacy Residents/New Practitioners - $125.00
• Pharmacy Technicians - $50.00
• Pharmacy Students - $50.00

Click Here To Register!

Seminar Schedule* 

7:30  - 8:00 am
Registration/Visit with Exhibitors

8:00 - 8:15 am
Opening Remarks

8:15 - 9:15 am (General Session)
Race-based prescribing for Black and African American Individuals with High Blood Pressure: Is it time for a change?
Presented by Abby Frye PharmD
Historically, treatment guidelines have recommended differential treatment of hypertension based on race. More specifically, these guidelines have recommended that Black and African American individuals without comorbidities should receive either a thiazide diuretic or a calcium channel blocker as initial therapy, while angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers should only be considered as initial therapy for Black and African American individuals with certain comorbidities such as chronic kidney disease. Recent studies indicate that these guidelines have affected clinical practice, but despite the use of more “evidence-based” monotherapies in Black and African American individuals the racial disparity in hypertension control is growing. This session will examine the available evidence regarding how and if we should be using race and other factors to guide the treatment of hypertension.
UAN: 0036-9999-23-229-L01-P/0036-9999-23-230-L01-T
Audience: RPh and CPT
Activity-Type: Application-based for RPh; Knowledge-based for CPT
Topic Designation: Disease State Management/Drug Therapy + Cultural Competence
Credit Hours: 1.0
RPh Learning Objectives:

1. Review the current hypertension treatment guidelines
2. Evaluate the impact of race-specific treatment recommendations for hypertension
3. Analyze the literature supporting race agnostic approach to hypertension management
4. Apply guidelines and literature to individualize treatment of hypertension

CPT Learning Objectives:

1. Review the current hypertension treatment guidelines
2. Evaluate the impact of race-specific treatment recommendations for hypertension
3. Discuss the literature supporting race agnostic approach to hypertension management

9:15-9:35 am
Visit with Exhibitors

9:35-10:35 am (Pharmacist Track)
Statewide Formulary, Novel Practices with Reimbursement
Presented by Lorinda Anderson PharmD, BCPS & Amy Valdez RPh
An update on the Oregon Public Health and Pharmacy Formulary Advisory Committee that makes recommendations on statewide protocols to the board of pharmacy. These protocols allow pharmacists to autonomously prescribe within their parameters and have increased pharmacist scope of practice within the state. We will review protocols currently approved and what the committee has been working on recently.
UAN: 0036-9999-23-221-L03-P/T
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Law Related to Pharmacy Practice
Credit Hours: 1.0
Learning Objectives:

1. Review the available statewide protocols in Oregon that allow pharmacists to prescribe under and what the overarching rules and regulations are that govern them
2. Explain how to engage with the Public Health and Pharmacy Formulary and Advisory Committee (PHPFAC) process from submitting ideas to serving as a subject matter expert
3. Identify the statewide protocols the PHPFAC is currently working on, and others that could be potentially developed

9:35-10:35 am (Technician Track)
Prior Authorization & REMS
Presented by Binh Tran CPhT, B.S. & Allison Mishkin CPhT
What is Prior Authorization in Healthcare? What is Prior Authorization in the Pharmacy world? How does Medication Prior Authorization affect oncology patients specifically?
We will introduce the REMS Program and highlight opportunities for CPhTs to get more involved.
UAN: 0036-9999-23-227-L04-T
Audience: CPT
Activity-Type: Application-based
Topic Designation: Pharmacy Administration
Credit Hours: 1.0
Learning Objectives:

1. Apply the information provided from today to assist in Prior Authorization process
2. Solve or assist the pharmacist to solve Medication Prior Authorization rejections/issues
3. Use the information provided to help patients getting medications in a timely manner and minimize delay in Medication Treatment
4. Demonstrate the unique services provided at OHSU for medication Prior Authorization process
5. Practice on improving communication workflow to assist in Prior Authorization process
6. Define the FDA REMS Program and describe various components of a REMS drug
7. Recognize some of the drugs/types that are in the REMS program and when the REMS program is applicable
8. Recall the role(s) a pharmacy technician has in a pharmacy that dispenses REMS drugs

10:35-10:55 am
Visit with Exhibitors

10:55-11:55 am (Pharmacist Track)
New CDC Opioid guidelines: What changed and What now for Pain?
Presented by Jessica Merlo PharmD, BCACP
The release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain had an incredible impact on the management of patients with chronic pain in the United States through changes seen in prescribing practices, insurance coverage, and regulations. Unfortunately, some of the changes inflicted by this guideline resulted in negative outcomes due to misinterpretation of guideline language and lack of person-centered decision making. With new data gathered, especially in relation to treatment of acute/subacute pain, the CDC recognized a need to provide more updated recommendations for prescribing opioids to improve pain management and patient safety. This presentation will review the impact of the 2016 guideline release, the rationale for creating an updated guideline, the major changes to the guideline, and how to incorporate this guideline into practice in order to make informed, individualized decisions about safe and effective treatment for pain care.
UAN: 0036-9999-23-222-L05-P/0036-9999-23-223-L05-T
Audience: RPh and CPT
Activity-Type: RPh – Application-based; CPT – Knowledge-based
Topic Designation: Patient Safety
Credit Hours: 1.0
RPH Learning Objectives:

1. Recognize the impact, including unintentional consequences, of the 2016 CDC Opioid Prescribing Guideline
2. Explain the CDC’s rationale for updating the 2016 CDC Opioid Prescribing Guideline
3. Summarize major additions and changes to the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain
4. Apply the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain to a patient case scenario for a patient with pain

CPT Learning Objectives:

1. Recognize the impact, including unintentional consequences, of the 2016 CDC Opioid Prescribing Guideline
2. Explain the CDC’s rationale for updating the 2016 CDC Opioid Prescribing Guideline
3. Summarize major additions and changes to the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for pain

10:55-11:55 am (Technician Track)
Technicians Career Ladder and Leadership
Presented by  Angela Koerner PharmD, BCACP, Europa Babbini CPhT, Kelli Johnson CPhT-Adv
Technician Ladder Implementation in Multiple Practice Settings
UAN: 0036-9999-23-228-L99-T
Audience: CPT
Activity-Type: Knowledge-based
Topic Designation: Additional Topic Areas
Credit Hours: 1.0
Learning Objectives

1. Describe process of a career ladder implementation in different pharmacy practice settings
2. Describe process of creating baseline and advance competencies to correspond with career ladder
3. Describe Technician Leadership opportunities

11:55 am -1:20 pm
Lunch with Program

1:20-2:20 pm (General Session Track)
Advances in the Management of Migraine
Presented by Kelsey Blom PharmD, BCACP
This presentation will review newly approved medications for acute and prophylactic treatment of migraine, including monoclonal antibodies, CGRP receptor antagonists, and the 5-HT1F receptor agonist. Patient cases will be incorporated to reinforce counseling points regarding use of medications, drug interactions, and adverse effects of therapy.
UAN: 0036-9999-23-224-L01-P/T
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0
RPh Learning Objectives:

1. Analyze the latest data on the efficacy, safety, and administration of recently approved therapies for the management of migraine
2. Recall important counseling points for use of the novel acute migraine medications
3. Recognize clinically significant drug interactions for newly approved migraine medications

CPT Learning Objectives:

1. Identify the names and therapeutic classes of newly approved migraine medications
2. Describe common side effects of newly approved migraine medications
3. Recall the strength, dosage forms, and routes of administration for newly approved migraine medications

1:20-3:25 pm (Student Session Track)
Dynamic Interviewing Skills and Feedback
Presented by YoungYoon Ham PharmD BCIDP
This session will be set up like a traditional classical music masterclass, with a number of students being given a chance to answer a standard interview question.  After answering the question, student will be given immediate feedback with concrete recommendations about how the answer could be adjusted.  Student will then re-answer the same question, repeating the process as many times as necessary to come to a satisfactory conclusion.  Other students can learn from the process while awaiting their turn.

2:25-3:25 pm (General Session)
Menopause Medicine: How Times Have Changed!
Presented by Karen Adams MD
We review current best practices for hormone therapy (HT) use, contraindications to HT, and non hormonal options for patients in whom HT is contraindicated.
UAN: 0036-9999-23-225-L01-P/T
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0
RPh Learning Objectives:

1. Discuss principal indications for systemic hormone therapy (HT)
2. List HT contraindications, risks, and benefits
3. Optimize and individualize HT options depending on the patient’s clinical characteristics

CPT Learning Objectives:

1. Discuss principal indications for systemic hormone therapy (HT)
2. List HT contraindications, risks, and benefits

3:25-3:45 pm
Break/Visit Posters

Poster Listing

3:45-4:45 pm (General Session)
What's New in Screening and Treating Tobacco Use Disorder
Presented by Julie Himstreet, PharmD
This presentation will review evidence-based approaches for tobacco use disorder. The 2021 US Preventative Services Task Force updated recommendations for tobacco cessation treatment will be overviewed. Opportunities for pharmacists to be involved in tobacco cessation treatment will be highlighted.
UAN: 0036-9999-23-226-L01-P/T
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0
Learning Objectives:

1. Define tobacco use disorder and how to incorporate the 5As into clinical practice
2. Review the types of tobacco products and electronic nicotine delivery systems (ENDS) and how this can affect a clinician’s approach to treatment
3. Identify evidence-based treatment approaches for tobacco use disorder
4. Explain the USPSTF 2021 updated recommendation regarding tobacco cessation treatment

5:00 pm
End of Seminar 

Click here to Learn More About our Presenters

*Schedule and content subject to change.

Going Green
In an effort to minimize paper waste, course handouts will be available online at www.oshp.org one week prior to the Seminar.  An email to access the materials will be e-mailed to you on October 30th. 

EXHIBIT OR SPONSOR AT THE OSHP 2023 FALL SEMINAR!  
The Board of Directors of the Oregon Society of Health-System Pharmacists invites you to participate as a Sponsor or Exhibitor at the 2023 Fall Seminar!

Exhibit Schedule

6:30 - 7:30 am | Exhibitor Set Up
7:30  - 8:00 am | Registration 
8:00 am - 4:55 pm | Education 
1:30 - 2:30 pm | Exhibitor Tear Down 

Fall Seminar Exhibit/Sponsor Fees

• Industry Exhibit:  $1,100 (OSHP Member) | $1,300 (Non Member)
• Residency Showcase Exhibit: $250
• Saturday Continental Breakfast - $1,00.00
• Saturday Lunch - $2,000.00
• Saturday AM Break - $250.00
• Saturday PM Break - $250.00
• Sponsor a Student - $250

Your exhibit registration includes a skirted display space, one chair and one lunch ticket. This is a ‘table top’ show, which means there is not draped off space for each exhibit, instead each exhibitor has the table space to display their items. 

Register to exhibit today!